Streetbeat News

Analyst Ratings

FLWS

DA Davidson has upgraded 1-800-Flowers.com from Underperform to Neutral, while lowering the price target from $8 to $7.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 3:59 pm

ARTV

Needham analyst Gil Blum has reiterated a Buy rating on Artiva Biotherapeutics (NASDAQ:ARTV) and maintained a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 3:58 pm

IREN

Compass Point analyst Chase White maintains a Buy rating on Iris Energy (NASDAQ:IREN) but lowers the price target from $18.5 to $16.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 3:55 pm

TRVI

HC Wainwright & Co. has initiated coverage on Trevi Therapeutics with a Buy rating and set a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 3:52 pm

ULTA

Canaccord Genuity has maintained a Buy rating on Ulta Beauty but lowered its price target from $500 to $442.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 3:47 pm

V

Deep-pocketed investors are showing a bullish sentiment towards Visa (NYSE:V) in the options market, with significant call options activity suggesting a potential price target between $250 and $290. The stock is currently trading at $275.06, with analysts maintaining an 'Overweight' rating and a target price of $320.

Portfolio Pulse from Benzinga Insights

August 30, 2024 | 3:46 pm

MDB

Needham analyst Mike Cikos has maintained a Buy rating on MongoDB and raised the price target from $290 to $335.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 3:44 pm

IREN

Canaccord Genuity analyst Joseph Vafi has reiterated a Buy rating for Iris Energy (NASDAQ:IREN) and maintained a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 3:43 pm

BTAI

Canaccord Genuity has reiterated its Buy rating for BioXcel Therapeutics, maintaining a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 3:42 pm